MENU
ELTX
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Elicio Therapeutics (ELTX) Ownership - Who owns Elicio Therapeutics?

Elicio Therapeutics Inc is a clinical-stage biotechnology company advancing novel immunotherapies for the treatment of cancer, including mKRAS-positive pancreatic cancer, colorectal cancer (CRC), lung cancer, and other mKRAS-positive cancers... Show more

Profile

Industry
N/A
Address
451 D Street
Phone
+1 857 209-0050
Employees
33
Web
https://www.elicio.com

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
50.99M
P/E Ratio
-0.90
Total Cash
23.48M
Projected Growth
N/A
Total Debt
14.15M
Revenue
N/A
Risk (Beta)
1.75
Dividend Yield
N/A
Total Cash/Share
0.89
Total Debt/Equity
N/A
Revenue/Share
null USD as % of share price
Who owns Elicio Therapeutics? ELTX symbol Ownership - Tickeron.com